ReviewVirulence2026
Chikungunya virus nsP2: Insights into viral replication, pathogenesis, and therapeutic targeting.
Review in Virulence, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chikungunya virus (CHIKV) poses a major global health challenge. Despite extensive research, effective antiviral treatments remain lacking, underscoring the urgent need for novel therapeutic strategies. The nonstructural (ns) polyprotein P1234, which is processed into enzymes essential for viral replication and disease progression. This review focuses on nsP2, a multifunctional enzyme possessing cysteine protease, nucleoside triphosphatase (NTPase), RNA helicase, and RNA triphosphatase (RTPase) activities. We summarize current knowledge of nsP2 structure and function and highlight its central roles in viral RNA replication, modulation of host antiviral responses, and immune evasion. Growing evidence identifies nsP2 as a key virulence factor and a promising antiviral target. By integrating recent advances in structural virology and host - pathogen interaction studies, this review provides insights that may guide rational design of nsP2-directed therapeutics. These insights not only deepen our understanding of CHIKV molecular biology but also contribute to broader strategies for combating emerging viral diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.